Herbal medicinal product: Origani majoranae herba, Origani majoranae herba, F: Assessment finalised

Human medicines European public assessment report (EPAR): Azomyr, desloratadine, Rhinitis, Allergic, Perennial;Urticaria;Rhinitis, Allergic, Seasonal, Date of authorisation: 15/01/2001, Revision: 52, Status: Authorised

Minutes of the COMP meeting 13-15 June 2023

HMPC meeting report on European Union herbal monographs, guidelines and other activities - 17-19 July 2023

Twelfth Paediatric Oncology Strategy Forum for Medicinal Product Development of CDK4/6, CDK7 and CDK9 Inhibitors in children and adolescents, Hybrid, from 26/10/2023 to 27/10/2023

Herbal medicinal product: Melaleucae aetheroleum, Melaleucae aetheroleum, F: Assessment finalised

Minutes - Enpr-EMA Coordinating Group and networks meeting

Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Arthroplasty, Replacement;Venous Thromboembolism, Date of authorisation: 30/09/2008, Revision: 40, Status: Authorised

Organisation chart: Stakeholders and Communication

Questions and answers (Q&As) on the external guidance of Policy 0070 on clinical data publication (CDP)